ArticleFrontiers in pharmacology2022

BCATc inhibitor 2 ameliorated mitochondrial dysfunction and apoptosis in oleic acid-induced non-alcoholic fatty liver disease model.

Zhuo Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.